Pacira BioSciences' Cash & Equivalents fell 40.00% to $147.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.6 million, marking a year-over-year decrease of 40.00%. This contributed to the annual value of $276.8 million for FY2024, which is 80.55% up from last year.
Latest data reveals that Pacira BioSciences reported Revenue - Interest and Investment Income of $97.9 million as of Q1 2011, which was up 47.03% from $66.6 million recorded in Q4 2010.
Pacira BioSciences' 5-year Revenue - Interest and Investment Income high stood at $97.9 million for Q1 2011, and its period low was $44.0 million during Q4 2009.
In the last 3 years, Pacira BioSciences' Cash & Equivalents had a median value of $184.1 million in 2024 and averaged $187.3 million.
Data for Pacira BioSciences' Revenue - Interest and Investment Income shows a peak YoY soared of 51.44% (in 2010) over the last 5 years.
Over the past 3 years, Pacira BioSciences' Revenue - Interest and Investment Income (Quarterly) stood at $44.0 million in 2009, then soared by 51.44% to $66.6 million in 2010, then reached $97.9 million in 2011.
Its last three reported values are $147.6 million in Q3 2025, $300.5 million for Q2 2025, and $283.6 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value